Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
PLoS One ; 18(9): e0291421, 2023.
Article in English | MEDLINE | ID: mdl-37683019

ABSTRACT

BACKGROUND: Infectious disease (ID) clinicians can provide essential services for febrile patients in tertiary hospitals. The aim of this study was to evaluate the role of ID consultations (IDC) in managing hospitalized patients with infections in an oriental medical hospital (OMH), which serves as a long-term care facility. To our knowledge, this is the first study on the role of IDCs in managing patients in an OMH. METHODS: This retrospective study was conducted in an OMH in Seoul, Korea, from June 2006 to June 2013. RESULTS: Among the 465 cases of hospital-acquired fever, 141 (30.3%) were referred for ID. The most common cause of fever was infection in both groups. The peak body temperature of the patient was higher in IDC group (38.8±0.6°C vs. 38.6±0.5°C, p<0.001). Crude mortality at 30 days (14.6% vs. 7.8%, p = 0.043) and infection-attributable mortality (15.3% vs. 6.7%, p = 0.039) were higher in the No-IDC group. Multivariable analysis showed that infection as the focus of fever (adjusted Odd ratio [aOR] 3.49, 95% confidence interval (CI) 1.64-7.44), underlying cancer (aOR 10.32, 95% CI 4.34-24.51,), and multiorgan dysfunction syndrome (aOR 15.68, 95% CI 2.06-119.08) were associated with increased 30-day mortality. Multivariate analysis showed that in patients with infectious fever, appropriate antibiotic therapy (aOR 0.19, 95% CI 0.05-0.76) was the only factor associated with decreased infection-attributable mortality while underlying cancer (aOR 7.80, 95% CI 2.555-23.807) and severe sepsis or septic shock at the onset of fever (aOR 10.15, 95% CI 1.00-102.85) were associated with increased infection-attributable mortality. CONCLUSION: Infection was the most common cause of fever in patients hospitalized for OMH. Infection as the focus of fever, underlying cancer, and MODS was associated with increased 30-day mortality in patients with nosocomial fever. Appropriate antibiotic therapy was associated with decreased infection-attributable mortality in patients with infectious fever.


Subject(s)
Cardiomyopathy, Dilated , Communicable Diseases , Humans , Long-Term Care , Retrospective Studies , Nursing Homes , Fever , Referral and Consultation , Tertiary Care Centers , Communicable Diseases/therapy
2.
J Infect Chemother ; 29(12): 1114-1118, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37572978

ABSTRACT

BACKGROUND: Considering that vertebral osteomyelitis (VO) can occur via various routes, it can be predicted that clinical characteristics may vary depending on the route of infection or risk factors of the disease. In this study, differences in clinical characteristics, causative pathogens, clinical features and prognosis were investigated in patients of native vertebral osteomyelitis with history of acupuncture. METHODS: This retrospective study was conducted at Kyung Hee University Hospital at Gangdong, Seoul. We extracted data of patients diagnosed with VO from May 2006 to February 2021 using an electronic database. Data on demography, clinical presentation, treatment, causative organisms and clinical outcomes were identified and compared according to the history of acupuncture. RESULTS: A total of 100 patients with VO were reviewed, among which 34 patients had a history of acupuncture prior to the diagnosis of VO. The frequency of Gram-positive cocci (GPC) was significantly higher in the acupuncture group than in the non-acupuncture group (p = 0.016). Abscess was observed more frequently in the acupuncture group than in the non-acupuncture group (p = 0.01). There was no difference in neurological sequelae and recurrence between the two groups. There was no difference in mortality between the two groups. (p = 0.098) CONCLUSION: This study suggests that confirming a history of acupuncture may help predict the pathogen or clinical characteristics of the disease. If the patient has a history of acupuncture, GPC can be considered as the causative organism, and the findings that abscesses and surgical treatment are more common may be helpful in evaluating patients.


Subject(s)
Acupuncture Therapy , Osteomyelitis , Humans , Retrospective Studies , Prognosis , Abscess , Acupuncture Therapy/adverse effects , Osteomyelitis/diagnosis
3.
Medicina (Kaunas) ; 59(1)2023 Jan 11.
Article in English | MEDLINE | ID: mdl-36676769

ABSTRACT

Gemella bergeri, a member of the genus Gemella, is a facultatively anaerobic, Gram-positive cocci. G. bergeri is a component of normal oral flora; however, it can become pathogenic and cause infections in patients with poor oral hygiene. A 78-year-old man was admitted to a hospital with a complaint of increasing posterior neck pain and lower back pain for 2 weeks. MRI was suggestive of infectious spondylitis at the C3-C4 level with prevertebral abscess formation, anterior epidural abscess formation. We identified Gemella bergeri in closed pus obtained during the surgery. Herein, we describe the first case of infective spondylitis caused by G. bergeri.


Subject(s)
Gemella , Gram-Positive Bacterial Infections , Gram-Positive Cocci , Spondylitis , Male , Humans , Aged , Abscess , Spondylitis/diagnostic imaging
4.
Anaerobe ; 73: 102477, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34780915

ABSTRACT

We report the first case of Slackia exigua bacteremia related to pyometra. Slackia exigua is an anaerobe that is usually found in the oral cavity and periodontal infections. After two months of treatment with antimicrobial agents, the patient recovered from infection.


Subject(s)
Actinobacteria , Bacteremia , Pyometra , Bacteremia/diagnosis , Bacteremia/drug therapy , Dentition , Humans
5.
Medicina (Kaunas) ; 57(8)2021 Aug 02.
Article in English | MEDLINE | ID: mdl-34441003

ABSTRACT

BACKGROUND: Kytococcus species has not been considered a pathogen, but infections caused by this species are increasing. There are several cases of infections caused by Kytococcus sedentarius, but no case of infectious spondylitis has been reported yet. CASE PRESENTATION: A 79-year-old female patient was hospitalized because of back pain for several months. She was diagnosed with infectious spondylitis, and K. sedentarius was cultured from the pus and specimen obtained during the surgical procedure. The patient recovered completely without recurrence after 6 months of treatment with ciprofloxacin alone for 8 weeks. CONCLUSION: This is the first case report of infectious spondylitis caused by K. sedentarius.


Subject(s)
Spondylitis , Actinobacteria , Aged , Female , Humans , Spondylitis/diagnostic imaging , Spondylitis/drug therapy
6.
BMC Pulm Med ; 19(1): 190, 2019 Oct 30.
Article in English | MEDLINE | ID: mdl-31666061

ABSTRACT

BACKGROUND: In 2015, South Korea experienced an outbreak of Middle East respiratory syndrome (MERS), and our hospital experienced a nosocomial MERS infection. We performed a comprehensive analysis to identify the MERS transmission route and the ability of our routine infection-prevention policy to control this outbreak. METHODS: This is a case-cohort study of retrospectively analysed data from medical charts, closed-circuit television, personal interviews and a national database. We analysed data of people at risk of MERS transmission including 228 in the emergency department (ED) and 218 in general wards (GW). Data of personnel location and movement, personal protection equipment and hand hygiene was recorded. Transmission risk was determined as the extent of exposure to the index patient: 1) high risk: staying within 2 m; 2) intermediate risk: staying in the same room at same time; and 3) low risk: only staying in the same department without contact. RESULTS: The index patient was an old patient admitted to our hospital. 11 transmissions from the index patient were identified; 4 were infected in our hospital. Personnel in the ED exhibited higher rates of compliance with routine infection-prevention methods as observed objectively: 93% wore a surgical mask and 95.6% washed their hands. Only 1.8% of personnel were observed to wear a surgical mask in the GW. ED had a higher percentage of high-risk individuals compared with the GW (14.5% vs. 2.8%), but the attack rate was higher in the GW (16.7%; l/6) than in the ED (3%; 1/33). There were no transmissions in the intermediate- and low-risk groups in the ED. Otherwise 2 patients were infected in the GW among the low-risk group. MERS were transmitted to them indirectly by staff who cared for the index patient. CONCLUSIONS: Our study provide compelling evidence that routine infection-prevention policies can greatly reduce nosocomial transmission of MERS. Conventional isolation is established mainly from contact tracing of patients during a MERS outbreak. But it should be extended to all people treated by any medical employee who has contact with MERS patients. TRIAL REGISTRATION: NCT02605109 , date of registration: 11th November 2015.


Subject(s)
Coronavirus Infections/transmission , Cross Infection/prevention & control , Emergency Service, Hospital , Infectious Disease Transmission, Professional-to-Patient , Patients' Rooms , Adult , Aged , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Cross Infection/transmission , Disease Outbreaks/statistics & numerical data , Female , Health Personnel/statistics & numerical data , Humans , Incidence , Male , Middle Aged , Middle East Respiratory Syndrome Coronavirus/isolation & purification , Occupational Exposure/statistics & numerical data , Republic of Korea/epidemiology , Retrospective Studies , Risk Factors , Tertiary Care Centers , Young Adult
7.
BMC Health Serv Res ; 18(1): 88, 2018 02 07.
Article in English | MEDLINE | ID: mdl-29415715

ABSTRACT

BACKGROUND: Traditional Oriental medicine is used in many Asian countries and involves herbal medicines, acupuncture, moxibustion, and cupping. We investigated the incidence and causes of hospital-acquired fever (HAF) and the characteristics of febrile inpatients in Oriental medical hospitals (OMHs). METHODS: Patients hospitalized in two OMHs of a university medical institute in Seoul, Korea, were retrospectively reviewed from 2006 to 2013. Adult patients with HAF were enrolled. RESULTS: There were 560 cases of HAF (5.0%). Infection, non-infection, and unknown cause were noted in 331 cases (59.1%), 109 cases (19.5%), and 120 cases (21.4%) of HAF, respectively. Respiratory tract infection was the most common cause (51.2%) of infectious fever, followed by urinary tract infection. Drug fever due to herbal medicine was the most common cause of non-infectious fever (53.1%), followed by procedure-related fever caused by oriental medical procedures. The infection group had higher white blood cell count (WBC) (10,400/mm3 vs. 7000/mm3, p < 0.001) and more frequent history of antibiotic therapy (29.6% vs. 15.1%, p < 0.001). Multivariate analysis showed that older age (odds ratio (OR) 1.67, 95% confidence interval (C.I.) 1.08-2.56, p = 0.020), history of antibiotic therapy (OR 3.17, C.I. 1.85-5.41, p < 0.001), and WBC > 10,000/mm3 (OR 2.22, C.I. 1.85-3.32, p < 0.001) were associated with infection. CONCLUSIONS: Compared to previous studies on HAF in Western medicine, the incidence of HAF in OMHs was not high. However, Oriental medical treatment does play some role in HAF. Fever in patients with history of antibiotic therapy, or high WBC was more likely of infectious origin.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Fever/chemically induced , Hospitals , Medicine, East Asian Traditional/adverse effects , Respiratory Tract Infections/chemically induced , Urinary Tract Infections/chemically induced , Age Factors , Aged , Female , Fever/drug therapy , Humans , Incidence , Inpatients , Leukocyte Count , Male , Middle Aged , Odds Ratio , Republic of Korea , Respiratory Tract Infections/drug therapy , Retrospective Studies
8.
Mycoses ; 60(8): 488-492, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28378904

ABSTRACT

Fungal otomastoiditis is a rare disease, but can be fatal for immunocompromised patients. Recently, there have been increasing cases of otologic infection caused by Candida auris. Candida auris can be easily misdiagnosed for other species and treatment is difficult due to multidrug resistance. Clinician should be aware of this rare pathogen, and it should be treated with appropriate antifungal agent with surgical debridement.


Subject(s)
Candida/isolation & purification , Candidiasis/microbiology , Mastoiditis/microbiology , Otitis/microbiology , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Candida/classification , Candida/drug effects , Candida/genetics , Candidiasis/diagnosis , Candidiasis/drug therapy , Candidiasis/surgery , Debridement , Fluconazole/pharmacology , Fluconazole/therapeutic use , Humans , Male , Mastoiditis/diagnostic imaging , Mastoiditis/drug therapy , Mastoiditis/surgery , Microbial Sensitivity Tests , Middle Aged , Middle Ear Ventilation , Otitis/diagnostic imaging , Otitis/drug therapy , Otitis/surgery , RNA, Ribosomal/genetics , Tomography, X-Ray Computed
10.
Infection ; 45(1): 67-74, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27541039

ABSTRACT

PURPOSE: Various immunocompromised conditions increase the risk of meningitis caused by Listeria monocytogenes. However, the relative importance of these risk factors has not been well established. We determined the risk factors that predict meningitis due to L. monocytogenes compared to that caused by Streptococcus pneumoniae. METHODS: A nationwide multicenter case-control study was conducted in Korea. Cases of meningitis caused by L. monocytogenes between 1998 and 2013 were included. Patients with pneumococcal meningitis were included as controls. Multivariate logistic regression analysis was used to predict the risk factors of Listeria meningitis. RESULTS: A total of 36 cases and 113 controls were enrolled. The most significant predictive risk factor of Listeria meningitis was a prior history of receiving immunosuppressive therapy (odds ratio 8.12, 95 % CI 2.47-26.69). Chronic liver disease was the second most important predictive risk factor (OR 5.03, 95 % CI 1.56-16.22). Delaying appropriate antibiotic therapy by more than 6 h (hazard ratio 2.78) and fatal underlying disease (hazard ratio 2.88) were associated with increased mortality. CONCLUSIONS: Patients with a prior history of receiving immunosuppressive therapy within 1 month and chronic liver disease have 8.1-fold and 5-fold increased risk of meningitis by L. monocytogenes compared to S. pneumoniae, respectively.


Subject(s)
Listeria monocytogenes , Meningitis, Listeria/epidemiology , Meningitis, Pneumococcal/epidemiology , Adult , Aged , Case-Control Studies , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Republic of Korea/epidemiology , Risk Factors , Treatment Outcome
13.
Diagn Microbiol Infect Dis ; 83(3): 286-91, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26277619

ABSTRACT

We evaluated the clinical significance of the cefazolin inoculum effect (CIE) in methicillin-susceptible Staphylococcus aureus (MSSA) isolates. In total, 146 isolates were recovered from patients with MSSA bacteremia at 9 hospitals in Korea. The CIE was observed in 16 MSSA isolates, and while type A was the only detected ß-lactamase in MSSA isolates exhibiting the CIE, no strains expressing type B, C, or D ß-lactamases exhibited this effect. The CIE was only observed in agr group III and I isolates and was significantly more common in isolates with agr dysfunction than in those with functional agr (P<0.001). Even among isolates producing type A ß-lactamase, the CIE was also prevalent in isolates with dysfunctional agr than in isolates with functional agr (P=0.025). This study demonstrates an association between the CIE of MSSA isolates and agr dysfunction, in addition to those between the CIE and type A ß-lactamase.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cefazolin/pharmacology , Drug Tolerance , Staphylococcus aureus/drug effects , Staphylococcus aureus/enzymology , Trans-Activators/deficiency , beta-Lactamases/metabolism , Adult , Aged , Aged, 80 and over , Bacteremia/microbiology , Bacterial Proteins , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Republic of Korea , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , beta-Lactamases/classification
14.
Diagn Microbiol Infect Dis ; 81(1): 60-5, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25459498

ABSTRACT

Although most Klebsiella pneumoniae liver abscesses have been reported to be monomicrobial, clinical outcomes have not been compared between antimicrobial therapy with and without anti-anaerobic coverage. A propensity score-matched cohort study was conducted using the 731 cases of K. pneumoniae liver abscess. Clinical outcomes were compared between a group discontinuing anti-anaerobic agents after K. pneumoniae identification and a group continuing. A total of 170 cases were matched at a 1:1 ratio using their propensity to discontinue anti-anaerobic agents. The McNemar's test showed no difference in mortality rates (1.8% for discontinuation versus 2.3% for continuation; P = 1.00) or relapse (1.8% versus 2.9%; P = 0.73) between groups. Early discontinuation of anti-anaerobic agents had no association with treatment failure by means of the generalized estimating equation model (odds ratio 0.48; P = 0.14) and the Kaplan-Meier method (P = 0.85) in matched groups. Early discontinuation of anti-anaerobic agents does not affect the clinical outcomes of patients with K. pneumoniae liver abscess.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Klebsiella Infections/drug therapy , Klebsiella pneumoniae/pathogenicity , Liver Abscess, Pyogenic/drug therapy , Aged , Cohort Studies , Female , Humans , Klebsiella Infections/microbiology , Klebsiella Infections/mortality , Liver Abscess, Pyogenic/microbiology , Liver Abscess, Pyogenic/mortality , Logistic Models , Male , Metronidazole/adverse effects , Metronidazole/therapeutic use , Middle Aged , Propensity Score , Retrospective Studies , Risk Factors , Treatment Outcome
15.
Antimicrob Agents Chemother ; 57(11): 5536-42, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23979741

ABSTRACT

Vancomycin has been a key antibiotic agent for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. However, little is known about the relationship between vancomycin MIC values at the higher end of the susceptibility range and clinical outcomes. The aim of this study was to determine the impact of MRSA bacteremia on clinical outcomes in patients with a vancomycin MIC near the upper limit of the susceptible range. Patients with MRSA bacteremia were divided into a high-vancomycin-MIC group (2 µg/ml) and a low-vancomycin-MIC group (≤1.0 µg/ml). We examined the relationship between MIC, genotype, primary source of bacteremia, and mortality. Ninety-four patients with MRSA bacteremia, including 31 with a high vancomycin MIC and 63 with a low MIC were analyzed. There was no significant difference between the presence of agr dysfunction and SCCmec type between the two groups. A higher vancomycin MIC was not found to be associated with mortality. In contrast, high-risk bloodstream infection sources (hazard ratio [HR], 4.63; 95% confidence interval [CI] = 1.24 to 17.33) and bacterial eradication after treatment (HR, 0.06; 95% CI = 0.02 to 0.17), irrespective of vancomycin MIC, were predictors of all-cause 30-day mortality. Our study suggests that a high-risk source of bacteremia is likely to be associated with unfavorable clinical outcomes, but a high vancomycin MIC in a susceptible range, as well as genotype characteristics, are not associated with mortality.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Methicillin-Resistant Staphylococcus aureus/drug effects , Staphylococcal Infections/drug therapy , Vancomycin/therapeutic use , Aged , Bacteremia/microbiology , Bacteremia/mortality , Bacterial Typing Techniques , Dose-Response Relationship, Drug , Female , Genotype , Humans , Male , Methicillin-Resistant Staphylococcus aureus/genetics , Methicillin-Resistant Staphylococcus aureus/growth & development , Microbial Sensitivity Tests , Middle Aged , Staphylococcal Infections/microbiology , Staphylococcal Infections/mortality , Survival Analysis , Treatment Outcome
16.
Microb Drug Resist ; 18(6): 562-6, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22775562

ABSTRACT

BACKGROUND: Tigecycline has broad spectrum antimicrobial activity and is approved for complicated intra-abdominal infections, complicated skin and soft tissue infections, and community-acquired pneumonia. There are few data on clinical experience of tigecycline in hospital-acquired pneumonia (HAP) and Acinetobacter spp. infection. METHODS: A retrospective study was performed at eight hospitals in Korea from May 2009 to January 2010. Adult patients treated with tigecycline regardless of their source of infection or pathogens were enrolled. RESULTS: Tigecycline was administered in 108 patients. Pneumonia was the most common infection (43.5%), followed by skin and soft tissue infections (20.4%). Acinetobacter baumannii was isolated from 83 patients (76.9%) accounting for 50.3% of isolated pathogens, showing a resistance rate of 67.5% to carbapenems. Superinfection was identified in 32 patients (29.6%). Pseudomonas aeruginosa was most common microorganism causing superinfection (46.9%). Overall 30-day mortality rate was 52.9%. Thirty-day mortality rate of HAP and Acinetobacter spp. infection was 60.5% and 59.4%, respectively. CONCLUSION: Tigecycline can be considered as an alternative therapy in patients with HAP or infections caused by Acinetobacter spp., especially extensively drug-resistant A. baumannii.


Subject(s)
Acinetobacter Infections/drug therapy , Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/therapeutic use , Community-Acquired Infections/drug therapy , Minocycline/analogs & derivatives , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Acinetobacter Infections/epidemiology , Acinetobacter Infections/microbiology , Acinetobacter Infections/mortality , Acinetobacter baumannii/isolation & purification , Acinetobacter baumannii/pathogenicity , Aged , Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Carbapenems/therapeutic use , Coinfection , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Community-Acquired Infections/mortality , Female , Humans , Male , Middle Aged , Minocycline/pharmacology , Minocycline/therapeutic use , Pseudomonas Infections/epidemiology , Pseudomonas Infections/microbiology , Pseudomonas Infections/mortality , Pseudomonas aeruginosa/isolation & purification , Pseudomonas aeruginosa/pathogenicity , Republic of Korea/epidemiology , Retrospective Studies , Survival Rate , Tigecycline , beta-Lactam Resistance/drug effects
17.
J Korean Med Sci ; 27(5): 553-5, 2012 May.
Article in English | MEDLINE | ID: mdl-22563223

ABSTRACT

We describe the first case of primary peritonitis in Korea of a healthy person due to Streptococcus pyogenes. In the absence of comorbid conditions, such as liver cirrhosis, immunosuppression, or nephrotic syndrome, primary peritonitis is uncommon in a young healthy woman. Abdomen computed tomography revealed ascites in the lower abdomen and peritoneal enhancement suggesting peritonitis. In diagnostic laparoscopy, purulent ascites was found in the pelvic cavity but both ovaries and fallopian tubes were intact. There were no intra-abdominal abnormalities such as bowel perforation, appendicitis, or necrosis. The reports of blood culture, ascites culture, and cervical swab culture confirmed S. pyogenes. After use of antibiotics, the patient was cured and discharged without sequelae.


Subject(s)
Peritonitis/diagnosis , Streptococcal Infections/diagnosis , Streptococcus pyogenes/isolation & purification , Adult , Anti-Bacterial Agents/therapeutic use , Female , Humans , Laparoscopy , Peritonitis/drug therapy , Peritonitis/microbiology , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Tomography, X-Ray Computed
18.
J Neurol ; 259(7): 1453-60, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22222857

ABSTRACT

The role of adjunctive corticosteroids remains controversial in meningitis by penicillin-resistant pneumococci. We determined the effect of adjunctive corticosteroids in adults with pneumococcal meningitis in a region with a high rate of penicillin resistance. A multicenter, retrospective cohort study was conducted between 1998 and 2008 in Korea. The mortality and neurological sequelae were evaluated. Among 93 patients with pneumococcal meningitis, adequate adjunctive corticosteroids were given in 45.2%. The penicillin resistance rate was 60.0%, and 42.1% were nonsusceptible to ceftriaxone. The 30-day mortality rates in the group receiving adequate corticosteroid therapy, the group in which corticosteroid was not given, and that inadequately given were 24.3, 31.6, and 27.3%, respectively, and there was no difference between the groups. The rates of development of neurological sequelae were 34.3, 33.3, and 43.5%, respectively. Multivariate analysis showed that adequate corticosteroids did not reduce mortality (HR 0.773, 95% CI 0.293-2.040) and neurologic sequelae (HR 0.604, CI 0.262-1.393). Propensity-adjusted analysis showed that adjunctive corticosteroid was not associated with time to death (HR 0.949, CI 0.374-2.408), however, a decreasing tendency was shown in neurologic sequelae in the adequate corticosteroid group (HR 0.479, CI 0.207-1.110). In conclusion, adjunctive corticosteroids did not affect mortality in adults with pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone; however, the patients receiving adequate corticosteroid therapy tended to develop neurologic sequelae less frequently.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Meningitis, Pneumococcal/drug therapy , Meningitis, Pneumococcal/mortality , Adult , Aged , Anti-Bacterial Agents/adverse effects , Ceftriaxone/adverse effects , Cohort Studies , Female , Humans , Kaplan-Meier Estimate , Male , Meningitis, Pneumococcal/microbiology , Middle Aged , Penicillin Resistance/drug effects , Penicillins/adverse effects , Retrospective Studies , Streptococcus pneumoniae/pathogenicity , Survival Rate , Time Factors , Treatment Outcome
19.
Support Care Cancer ; 20(10): 2371-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22193772

ABSTRACT

OBJECTIVES: The aim of this study was to more precisely delineate the characteristics and outcomes of bloodstream infections in adult cancer patients. METHODS: Using a database for nationwide surveillance of bacteremia, we analyzed data related to bacteremia in adult patients with cancer in order to evaluate clinical features and outcomes and to define predictive factors for mortality. RESULTS: Of 1,246 patients, 896 (71.9%) had solid tumors, 328 (26.3%) had hematologic malignancies, and 22 (1.8%) had both. The following conditions were more common in the neutropenic group than in the non-neutropenic group: nosocomial acquisition, hematologic malignancy, corticosteroid use, immunosuppressant use, primary bacteremia, and pneumonia (all P < 0.05). The infections were caused by Gram-negative bacilli in 55.6% and by Gram-positive cocci in 32.7%. Gram-negative pathogens were more frequently isolated from neutropenic patients than from non-neutropenic patients (61.9% vs. 53.5%, P = 0.010), with a significant predominance of Escherichia coli and Klebsiella pneumoniae. Among 1,001 patients whose outcomes could be evaluated, the overall 30-day mortality rate was 24.1%, and multivariate analysis showed that Staphylococcus aureus bacteremia was a significant factor associated with mortality (odds ratio (OR), 1.80; 95% confidence interval (CI), 1.03-3.15), along with nosocomial acquisition, pneumonia, severe sepsis or septic shock, and higher Pitt bacteremia score (all P values <0.05). CONCLUSION: This study represents the comprehensive assessment of bloodstream infections in neutropenic versus non-neutropenic cancer patients. Given the pathogenic significance of S. aureus bacteremia in adult patients with cancer, additional strategies for the management of S. aureus bacteremia in cancer patients are needed to improve outcomes.


Subject(s)
Bacteremia/microbiology , Cross Infection/microbiology , Neoplasms/complications , Neutropenia/microbiology , Staphylococcal Infections/blood , Staphylococcus aureus , Adult , Aged , Bacteremia/mortality , Bacteremia/physiopathology , Bacteria/classification , Cross Infection/blood , Female , Humans , Male , Middle Aged , Population Surveillance , Republic of Korea
20.
J Infect ; 63(5): 336-43, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21835195

ABSTRACT

OBJECTIVE: The purpose of this study was to evaluate clinical features and outcomes of bacteremia in patients with liver cirrhosis (LC) and determine whether underlying LC is an independent risk factor for mortality in a population of patients with different underlying diseases. METHODS: From the database of nationwide surveillance studies for bacteremia, data regarding bacteremia in patients with LC were analyzed and compared with those in patients with other diseases. RESULTS: A total of 195 patients with LC were compared with 1659 patients with other underlying diseases. As for the site of infection, intraabdominal infection was more frequent in the LC group (P < 0.001), while pneumonia, urinary tract bacteremia, and primary bacteremia were more prevalent in the other diseases group (all P < 0.05). Patients with LC were more likely to have Klebsiella pneumoniae bacteremia (20.1% vs. 14.3%, P = 0.018), but less likely to have coagulase-negative staphylococcal bacteremia (5.1% vs. 10.4%, P = 0.028). The 30-day mortality rate was significantly higher in the LC group compared to the other disease group (27.2% [53/195] vs. 20.3% [336/1659], P = 0.025). Multivariate analysis revealed underlying LC as a significant predictor for mortality (OR, 2.11; 95% CI, 1.43-3.13; P < 0.001), along with old age, nosocomial acquisition, pneumonia, severe sepsis, and a higher Pitt bacteremia score. CONCLUSIONS: The mortality rate of patients with LC was significantly higher than that of patients with other diseases when they developed bacteremia. Underlying LC was found to be one of the independent risk factors for mortality in patients with bacteremia.


Subject(s)
Bacteremia/mortality , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Liver Cirrhosis/complications , Aged , Bacteremia/complications , Bacteremia/epidemiology , Case-Control Studies , Cohort Studies , Demography , Female , Humans , Liver Cirrhosis/epidemiology , Liver Cirrhosis/mortality , Male , Middle Aged , Multivariate Analysis , Republic of Korea/epidemiology , Retrospective Studies , Risk Factors , Sentinel Surveillance , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...